tiprankstipranks

EDMUND HARRIGAN Insider Profile

4 Followers
EDMUND HARRIGAN, Director at ACADIA Pharmaceuticals, holds 19.00K shares in ACADIA Pharmaceuticals (Ticker: ACAD), holds ― shares in Bellicum Pharmaceuticals (Ticker: BLCM), holds 9.75K shares in Phasebio Pharmaceuticals (Ticker: PHASQ).
tipranks
EDMUND HARRIGAN

EDMUND HARRIGAN
ACADIA Pharmaceuticals (ACAD)
Director

Not Ranked
EDMUND HARRIGAN has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$996K
68.08%
31.89%
0.02%
A breakdown of EDMUND HARRIGAN's holdings

Insider Roles

Incyte
(INCY)
Director
ACADIA Pharmaceuticals
(ACAD)
Director
Phasebio Pharmaceuticals
(PHASQ)
Director
Roles that EDMUND HARRIGAN holds in companies

Most Profitable Insider Trade

Stock:
ACADIA Pharmaceuticals
(ACAD)
Rating:Informative Buy
Date:Aug 18, 2016 - Aug 18, 2017
Return:-6.50%
The most profitable trade made by EDMUND HARRIGAN

EDMUND HARRIGAN's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ACADIA Pharmaceuticals
Jun 05, 2023
Director
Uninformative Buy
$317.52K
BLCM
Bellicum Pharmaceuticals
Phasebio Pharmaceuticals
Director
$234.00
KRTX
Karuna Therapeutics
Aug 14, 2020
Uninformative Sell
833.20K
$18.19M
Incyte
Apr 02, 2024
Director
Uninformative Buy
23.53K
$677.78K
List of latest transactions for each holding click on a transaction to see EDMUND HARRIGAN's performance on stock

EDMUND HARRIGAN insider profile FAQ

What is the percentage of profitable transactions made by EDMUND HARRIGAN?
The percentage of profitable transactions made by EDMUND HARRIGAN is ―.
    What is the average return per transaction made by EDMUND HARRIGAN?
    The average return per transaction made by EDMUND HARRIGAN is ―.
      What stocks does EDMUND HARRIGAN hold?
      EDMUND HARRIGAN holds: ACAD, BLCM, PHASQ, KRTX, INCY stocks.
        What was EDMUND HARRIGAN’s latest transaction?
        EDMUND HARRIGAN latest transaction was an Uninformative Buy of ―.
          What was EDMUND HARRIGAN's most profitable transaction?
          EDMUND HARRIGAN’s most profitable transaction was an Informative Buy of ACAD stock on August 18, 2016. The return on the trade was -6.50%.
            What is EDMUND HARRIGAN's role in ACADIA Pharmaceuticals?
            EDMUND HARRIGAN's role in ACADIA Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.